INFLUENCE OF OMEGA-CONOTOXIN ON MORPHINE ANALGESIA AND WITHDRAWAL SYNDROME IN RATS

被引:21
作者
BASILICO, L
PAROLARO, D
RUBINO, T
GORI, E
GIAGNONI, G
机构
[1] Institute of Pharmacology, Faculty of Sciences, University of Milan, Milan
关键词
OMEGA-CONOTOXIN; MORPHINE; ANALGESIA; WITHDRAWAL SYNDROME;
D O I
10.1016/0014-2999(92)90149-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of omega-conotoxin on opiate analgesia and withdrawal syndrome was investigated in rats. Omega-conotoxin given i.c.v. and i.p. caused weak analgesia in the tail-flick test. When the toxin (20 ng/rat) was given i.c.v. immediately before morphine (1.5-mu-g/rat i.c.v.) the resultant analgesic effect was additive. In contrast, the analgesia elicited by morphine (3-mu-g/rat i.c.v.) was greatly reduced after 24-h pretreatment with the toxin (20 ng/rat i.c.v.). The systemic administration of the toxin (10-mu-g/kg i.p.) did not affect morphine analgesia whether omega-conotoxin was coadministered with morphine (2.5 mg/kg i.p.) or was given 24 h before thc opiate (5 mg/kg i.p.). Omega-conotoxin i.c.v. injected in morphine-dependent rats 15 min before naloxone challenge significantly attenuated the abstinence syndrome. On the contrary systemic administration of omega-conotoxin failed to suppress the morphine withdrawal syndrome. The present results suggest that omega-conotoxin affects both acute and chronic effects of morphine.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 51 条
[41]  
SCHMIDT WK, 1980, J PHARMACOL EXP THER, V212, P22
[42]   CALCIUM-CHANNEL BLOCKADE BY CERTAIN OPIOIDS [J].
SEYLER, DE ;
BOROWITZ, JL ;
MAICKEL, RP .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1983, 3 (06) :536-542
[43]   INTEGRATED AUTONOMIC AND BEHAVIORAL-RESPONSES TO L/N CA-2+-CHANNEL BLOCKER OMEGA-CONOTOXIN IN CONSCIOUS RATS [J].
SHAPIRA, S ;
ADEYEMO, OM ;
FEUERSTEIN, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (03) :R427-R438
[44]  
WAGNER JA, 1988, J NEUROSCI, V8, P3354
[45]  
WAY EL, 1979, P C HUNG PHARM SOC, P153
[46]  
WEI E, 1973, J PHARMACOL EXP THER, V184, P398
[47]   OPIATE WITHDRAWAL BEHAVIOR AFTER FOCAL BRAIN-STIMULATION [J].
WILLIAMS, DA ;
THORN, BE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1984, 21 (05) :699-703
[48]  
YAMAMOTO H, 1978, J PHARMACOL EXP THER, V205, P255
[49]  
YEAGER RE, 1987, J NEUROSCI, V7, P2390
[50]  
ZABOJNIKOVA M, 1984, ACTIV NERV SUPER, V26, P267